Seegene will manufacture reagents designed exclusively for Beckman Coulter's new Veris MDx sample-to-answer molecular diagnostics system.
Genome Compiler will integrate DNA2.0's gene synthesis services into its computer-aided synthetic biology design platform.
NEW YORK (GenomeWeb) – Biocept reported today that its third quarter net loss increased 34 percent year over year, as the firm expanded initiatives in its fledgling oncology diagnostics business.
NEW YORK (GenomeWeb) – Molecular diagnostics firm Great Basin Scientific reported after the close of the market Thursday that its third quarter revenues climbed 83 percent year over year due to sales of its Clostridium difficile test.
Look out next week for a major GenomeWeb redesign that will include a change to our weekly premium newsletters. PCR Insider will no longer publish on Fridays. Instead, you'll receive the PCR Bulletin, one of 10 new weekly topic-specific news mailings that will be available to all GenomeWeb Premium subscribers. You will be able to opt into any of the weekly mailings that you choose, so please visit your My Account page next week to set your email preferences!
NEW YORK (GenomeWeb) – Though reverse transcription of RNA to cDNA is an essential first step for a growing number of genomics applications, researchers have long known of problems associated with RT and its effects on study results.
Sequencing technologies were more prevalent than ever at the Association for Molecular Pathology's corporate workshop day.
The ability to identify vanishing twins and triploid pregnancies could lower the rate of false-positive results from NIPT, prevent incorrect calls on fetal sex, and help with clinical management of triploid pregnancies, Natera said.
NEW YORK (GenomeWeb) – Human Longevity today announced a collaboration with King's College London to access and sequence the college's TwinsUK Registry.
NEW YORK (GenomeWeb) – Response Genetics today said that its third quarter revenues rose 9 percent year over year on higher testing revenues and volumes.